Previous 10 | Next 10 |
home / stock / gsk / gsk articles
Saturday, GSK plc (NYSE:GSK) announced overall survival (OS) results from Part 1 and progression-free survival (PFS) results fr...
Pfizer Inc (NYSE:PFE) plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc (NYSE:HLN)&nbs...
New York, United States, March 12, 2024 (GLOBE NEWSWIRE) -- Contraception encompasses the use of drugs to prevent pregnancy, the transmission of...
ViiV Healthcare, majority owned by GSK Plc (NYSE:GSK), with Pfizer Inc (NYSE:PFE) and Shionogi Limited as shareholder...
The World Health Organization (WHO) released its latest HIV Drug Resistance (HIVDR) Report, shedding light on the growing areas of drug r...
The Biden administration is working to preserve a crucial federal mandate compelling health insurers to cover preventive care services, including ...
Haleon Plc’s (NYSE:HLN) fiscal year 2023 revenues increased 4.1% Y/Y to £11.3 billion, equivalent to around $14.03 billion, m...
Thursday, GSK Plc (NYSE:GSK) agreed to confidentially settle another lawsuit in California that had alleged its heartburn drug ...
Monday, GSK plc (NYSE:GSK) released headline results from the pivotal EAGLE-1 phase 3 trial for gepotidacin, an oral antibiotic...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 08:00:00 ET GSK (NYSE: GSK) , a global healthcare powerhouse, has been on a transformative journey since CEO Emma Walmsley took the helm in 2017. Despite its shares badly underperforming the S&P 500 under her first few years as CEO (see graph below), Walmsley's am...
2024-07-11 23:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 fl...